Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis

Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis

Background: With the introduction of sirolimus as medical therapy for lymphangioleiomyomatosis (LAM), an updated evaluation of LAM lung transplant (LT) outcomes and characterization of peritransplant sirolimus use is needed. Methods: We identified adult LT recipients from 2005-2021 using the Scienti...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily L. Larson, BS, Reed T. Jenkins, BA, Jessica M. Ruck, MD, Laura B. Zeiser, MS, Alice L. Zhou, MS, Alfred J. Casillan, MD, PhD, Dorry L. Segev, MD, Allan B. Massie, MD, Jinny S. Ha, MD, Pali D. Shah, MD, Christian A. Merlo, MD, MPH, Errol L. Bush, MD
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Annals of Thoracic Surgery Short Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2772993124003231
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items